TORRENT PHARMACEUTICALS
|
The Current P/E Ratio of TORRENT PHARMACEUTICALS is 56.84.
Share Price | ₹3,127.5 | Apr 11,2025 |
Market Cap | ₹105,834.6 Cr | |
Earnings-TTM | ₹1,862.0 Cr | TTM-Consolidated Results |
Price/Earnings | 56.84x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of TORRENT PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹105,834.6 Cr] as on Apr 11,2025
(/) Earnings [ ₹1,862.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 56.84x ]
Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay 56.84 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of TORRENT PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of TORRENT PHARMACEUTICALS
PE Ratio Performance Analysis for TORRENT PHARMACEUTICALS
- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 31.77x.
- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 30.45x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 53.15x.
- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 16.28x.
How does TORRENT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
TORRENT PHARMACEUTICALS | 1,862.00 | 56.84 | 105,834.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.25 | 404,900.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 71.83 | 148,474.0 |
CIPLA LTD | 5,000.43 | 23.63 | 118,166.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.05 | 92,553.6 |
MANKIND PHARMA LTD | 2,050.73 | 47.30 | 97,009.6 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.03 | 87,366.3 |
LUPIN LTD | 2,892.10 | 31.08 | 89,899.9 |
AUROBINDO PHARMA LTD | 3,500.25 | 17.96 | 62,874.7 |
ABBOTT INDIA LTD | 1,334.46 | 47.10 | 62,852.5 |
ALKEM LABORATORIES LTD | 2,197.47 | 26.55 | 58,351.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TORRENT PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.05x |
Max industry PE | 71.83x |
Median industry PE | 31.08x |
Average industry PE | 35.79x |
You may also like the below Video Courses